Clinical Scorecard: Expanding Perspectives: Reevaluating ICU Admission Criteria for Acute Leukemia Patients

At a Glance

Key Highlights

• Over 20% of acute leukemia patients require intensive care within a year of diagnosis.

• ICU mortality rates have improved from 90% to approximately 45% for patients requiring mechanical ventilation.

• The introduction of novel chemotherapy regimens and supportive care has contributed to improved outcomes.

• Age >65 years is identified as an adverse predictor of in-ICU mortality.

• Goals-of-care discussions are essential but remain uncommon in ICU settings.

Guideline-Based Recommendations

Diagnosis

• Consider comprehensive assessment of frailty and patient wishes prior to ICU admission.

Management

• Utilize novel non-cytotoxic strategies for older patients with acute myeloid leukemia.

Monitoring & Follow-up

• Monitor for complications such as tumor lysis syndrome and differentiation syndrome.

Risks

• Increased likelihood of treatment modifications post-ICU discharge, particularly in older patients.

Patient & Prescribing Data

Adults with acute leukemia, especially those aged >65 years.

Combination of hypomethylating agents with venetoclax is the standard for older patients ineligible for intensive chemotherapy.

Clinical Best Practices

• Encourage collaboration between intensivists and hematologists for optimal patient management.

• Incorporate goals-of-care discussions into ICU admission processes.

Related Resources & Content

1. Chean et al., Intensive Care Medicine, 2023 -- Temporal trends and prognostic factors in critically ill adult patients with acute leukemia: an individual participant data meta-analysis

2. Intensive Care Medicine — Emergency Chemotherapy Administration for Hematological Patients in Intensive Care Settings

3. The ASCO Post — Study Identifies Factors for Severe COVID-19 Illness Among Patients With Acute Leukemia or MDS

4. The Pathologist — Elevating the Treatment Standard in Older Patients with AML

5. Surviving Sepsis Campaign Adult Guidelines | SCCM

6. Management of critically ill cancer patients. Expert consensus statement of the iCHOP Working Group

7. British Journal of Haematology | Wiley Online Library

8. Apheresis procedures for the treatment of patients and for the collection of cellular therapy products: A British Society for Haematology guideline

9. the asco post — Expert Point of View: Marlise Luskin, MD

10. Surviving Sepsis Campaign Adult Guidelines | SCCM

11. Management of critically ill cancer patients. Expert consensus statement of the "Intensive Care for Hematology and Oncology Patients" (iCHOP) Working Group of the German Society of Hematology and Oncology (DGHO), Austrian Society of Hematology and Oncology (OeGHO), German Society for Medical Intensive Care Medicine and Emergency Medicine (DGIIN), and Austrian Society of Medical and General Intensive Care and Emergency Medicine (ÖGIAIN) - PubMed

12. British Journal of Haematology | Wiley Online Library

13. Apheresis procedures for the treatment of patients and for the collection of cellular therapy products: A British Society for Haematology guideline - Howell - 2025 - Transfusion Medicine - Wiley Online Library

14. Temporal trends and prognostic factors in critically ill adult patients with acute leukemia: an individual participant data meta-analysis - PubMed

15. Dynamic changes in mortality risk factors for acute leukemia patients in the ICU and Post-ICU periods | Annals of Hematology | Springer Nature Link

16. Factors associated with ICU mortality and long-term outcomes in immunocompromised patients admitted to the intensive care unit for acute respiratory failure | Annals of Intensive Care | Springer Nature Link

17. Critically ill adult patients with acute leukemia: a systematic review and meta-analysis - PMC